![FACS analysis of human peripheral blood lymphocytes using GTX01455-08 CD19 antibody [HIB19] (PE). Solid lone : primary antibody Dashed line : isotype control antibody amount : 0.25 microg (5 microl) FACS analysis of human peripheral blood lymphocytes using GTX01455-08 CD19 antibody [HIB19] (PE). Solid lone : primary antibody Dashed line : isotype control antibody amount : 0.25 microg (5 microl)](https://www.genetex.com/upload/website/prouct_img/normal/GTX01455-08/GTX01455-08_20200428_FACS100_w_23053121_847.webp)
FACS analysis of human peripheral blood lymphocytes using GTX01455-08 CD19 antibody [HIB19] (PE). Solid lone : primary antibody Dashed line : isotype control antibody amount : 0.25 microg (5 microl)
CD19 antibody [HIB19] (PE)
GTX01455-08
ApplicationsFlow Cytometry
Product group Antibodies
TargetCD19
Overview
- SupplierGeneTex
- Product NameCD19 antibody [HIB19] (PE)
- Delivery Days Customer9
- Application Supplier NoteFACS: 0.25 microg (5 microl) for 105-108 cells in 100 microl sample per test. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsFlow Cytometry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDHIB19
- Concentration0.05 mg/ml
- ConjugateRPE
- Gene ID930
- Target nameCD19
- Target descriptionCD19 molecule
- Target synonymsB4, CVID3, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, T-cell surface antigen Leu-12, differentiation antigen CD19
- HostMouse
- IsotypeIgG1
- Protein IDP15391
- Protein NameB-lymphocyte antigen CD19
- Scientific DescriptionLymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. [provided by RefSeq, Jul 2008]
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Richards KA, Moritzky S, Shannon I, et al. Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans. NPJ Vaccines. 2020,5:77. doi: 10.1038/s41541-020-00227-xRead this paper
- Zhao NQ, Vendrame E, Ferreira AM, et al. Natural killer cell phenotype is altered in HIV-exposed seronegative women. PLoS One. 2020,15(9):e0238347. doi: 10.1371/journal.pone.0238347Read this paper
- Stoszko M, Al-Hatmi AMS, Skriba A, et al. Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency. Sci Adv. 2020,6(33):eaba6617. doi: 10.1126/sciadv.aba6617Read this paper
- Benjelloun F, Quillay H, Cannou C, et al. Activation of Toll-Like Receptors Differentially Modulates Inflammation in the Human Reproductive Tract: Preliminary Findings. Front Immunol. 2020,11:1655. doi: 10.3389/fimmu.2020.01655Read this paper
- Krüger R, Martin E, Dmytrus J, et al. CD70 Deficiency Associated With Chronic Epstein-Barr Virus Infection, Recurrent Airway Infections and Severe Gingivitis in a 24-Year-Old Woman. Front Immunol. 2020,11:1593. doi: 10.3389/fimmu.2020.01593Read this paper
- Bézie S, Freuchet A, Sérazin C, et al. IL-34 Actions on FOXP3(+) Tregs and CD14(+) Monocytes Control Human Graft Rejection. Front Immunol. 2020,11:1496. doi: 10.3389/fimmu.2020.01496Read this paper
- Giron LB, Colomb F, Papasavvas E, et al. Interferon-α alters host glycosylation machinery during treated HIV infection. EBioMedicine. 2020,59:102945. doi: 10.1016/j.ebiom.2020.102945Read this paper
- Salzer B, Schueller CM, Zajc CU, et al. Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function. Nat Commun. 2020,11(1):4166. doi: 10.1038/s41467-020-17970-3Read this paper
- Kreye J, Reincke SM, Kornau HC, et al. A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model. bioRxiv. 2020,:pii: 2020.08.15.252320. doi: 10.1101/2020.08.15.252320.Read this paper
- Pierini S, Tanyi JL, Simpkins F, et al. Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target. JCI Insight. 2020,5(16):pii: 136773. doi: 10.1172/jci.insight.136773.Read this paper





